Oxikodon Depot Actavis 5 mg

Oxikodon Depot Actavis is a prescription pharmaceutical used for severe pain management. The generic drug contains oxycodone hydrochloride in a modified-release tablet form.

The brand Actavis has a complex corporate history. It was originally an Icelandic company that grew through numerous international acquisitions. In 2012, Actavis was acquired by Watson Pharmaceuticals, which later adopted the Actavis name. Eventually, the global generic business of Actavis was sold to Teva Pharmaceutical Industries Ltd in 2016.

Today, products bearing the Actavis name are part of the Teva group, one of the world's largest producers of generic medicines. Due to the global scale of Teva's operations, manufacturing for a specific batch in the Scandinavian market can take place in various specialized pharmaceutical plants across Europe or India.